Binaural Beats for Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing H… (NCT07735910) | Clinical Trial Compass
RecruitingNot Applicable
Binaural Beats for Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing Homes
China60 participantsStarted 2026-06-15
Plain-language summary
This study will evaluate whether binaural beats can improve cognitive function in older adults with mild cognitive impairment living in nursing homes. Participants will listen to 10-Hz alpha-frequency binaural beats through headphones once daily for 30 minutes for 14 consecutive days. Cognitive function, sleep quality, anxiety, and depressive symptoms will be assessed before the intervention, after the intervention, and at a 2-week follow-up after the intervention. The study aims to determine whether binaural beats are a safe, simple, and non-drug approach to support cognitive health in older adults with mild cognitive impairment.
Who can participate
Age range
60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age 60 years or older.
. Not previously diagnosed with dementia.
. Meets the diagnostic criteria for mild cognitive impairment, with Montreal Cognitive Assessment scores adjusted by education level, Mini-Mental State Examination score \>= 24, and Activities of Daily Living score \< 23.
. Has lived in a nursing home for more than 2 months and plans to continue living there during the study period.
. No hearing impairment; Hearing Handicap Inventory for the Elderly-Screening Version score \< 8, and able to hear binaural beats through both ears.
. Conscious and able to cooperate with questionnaires and scale assessments.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Montreal Cognitive Assessment Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
2
Change in Digit Span Test Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
3
Change in Stroop Color-Word Test Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
4
Change in Trail Making Test Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
5
Change in Pittsburgh Sleep Quality Index Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
6
Change in Geriatric Anxiety Scale Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention
. Has not taken medications that may affect cognitive function within 3 to 6 months before the intervention.
Exclusion criteria
. Severe physical disease, major organ failure, or advanced malignant tumor.
. Diagnosed depression or other psychiatric disorders.
. Serious adverse events during the study, such as falls, disease recurrence, discomfort caused by the intervention audio, death, or other conditions making continued participation unsuitable.
. Voluntary withdrawal from the study.
. Incomplete data resulting in missing information.
. Missing three or more intervention sessions within 2 weeks without following intervention instructions.
. Receiving other treatments or interventions related to cognitive function during the trial.
Change in Geriatric Depression Scale-15 Score
Timeframe: Baseline, immediately after the 14-day intervention, and 2 weeks after the intervention